Top

Clinical Research in Cardiology

Published in:

01-06-2018 | Letter to the Editors

Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years

Authors: Jan-Erik Guelker, Ruben Jansen, Kolja Sievert, Horst Sievert, Stefan Bertog

Published in: Clinical Research in Cardiology | Issue 6/2018

Excerpt

Sirs, …

King TD, Thompson SL, Steiner C, Mills NL (1976) Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235:2506–2509CrossRefPubMed

Berger F, Vogel M, Alexi-Meskishvili V, Lange PE (1999) Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 118:674–678CrossRefPubMed

Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J, Vincent R, Martin G, for the ACC IMPACT Steering Committee (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6:433–442CrossRefPubMed

U.S. FDA (2012) FDA Executive Summary Memorandum—May 24, 2012: Circulatory system advisory panel meeting—transcatheter ASD occluders: clinical update and review of events [pdf]. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/ucm300073.htm. Accessed 24 May 2012

Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H (2004) Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 43:302–309CrossRefPubMed

McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z (2016) Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation 133(18):1738–1746CrossRefPubMed

Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63(4):496–502CrossRefPubMed

El-Said HG, Moore JW (2009) Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 73(7):925–930CrossRefPubMed

Baumgartner H, Bonhoeffer P, De Groot NMS et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31:2915–2957CrossRefPubMed

10.

Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, Pome` G, Bossone E, Frigiola A (2006) Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 151:228–234CrossRefPubMed

11.

Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH (2003) Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 89:199–204CrossRefPubMedPubMedCentral

12.

Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39:1836–1844CrossRefPubMed

13.

Roberts WT, Parmar J, Rajathurai T (2013) Very late erosion of Amplatzer septal occludedevice presenting as pericardial pain and effusion 8 years after placement. Catheter Cardiovasc Interv 82:E592–E594CrossRefPubMed

14.

Amin Z (2014) Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv 83(1):84–92CrossRefPubMed

Title: Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years
Authors: Jan-Erik Guelker
Ruben Jansen
Kolja Sievert
Horst Sievert
Stefan Bertog
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 6/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1222-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry

Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy

Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial

The contribution of comorbidities to mortality in hospitalized patients with heart failure

Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study

Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page